This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Salud financiera de hoja de balance de Karo Pharma
Salud financiera controles de criterios 1/6
Información clave
104.8%
Ratio deuda-patrimonio
kr8.65b
Deuda
| Ratio de cobertura de intereses | 0.2x |
| Efectivo | kr353.10m |
| Patrimonio | kr8.26b |
| Total pasivo | kr10.24b |
| Activos totales | kr18.49b |
Actualizaciones recientes sobre salud financiera
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14
Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Recent updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality
Feb 24Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?
Feb 22Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?
Feb 01
Análisis de la situación financiera
Pasivos a corto plazo: KARO's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Pasivo a largo plazo: KARO's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: KARO's net debt to equity ratio (100.5%) is considered high.
Reducción de la deuda: KARO's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Cobertura de la deuda: KARO's debt is not well covered by operating cash flow (5.9%).
Cobertura de intereses: KARO's interest payments on its debt are not well covered by EBIT (0.2x coverage).